mebendazole has been researched along with Neutropenia in 5 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients receiving oral high-dose mebendazole therapy for echinococcosis were found to have severe, reversible neutropenia, apparently due to marrow suppression; platelets and RBCs were also reversibly suppressed in one." | 7.66 | Severe, reversible neutropenia during high-dose mebendazole therapy for echinococcosis. ( Axelrod, JL; Levin, MH; Schantz, PM; Weinstein, RA, 1983) |
| "The occurrence of transient leukopenia with relative neutropenia in a patient treated with a short course of high-dose mebendazole therapy for inoperable hydatid disease is reported." | 7.66 | Leukopenia associated with mebendazole therapy of hydatid disease. ( Javitt, NB; Miskovitz, PF, 1980) |
| "Two patients receiving oral high-dose mebendazole therapy for echinococcosis were found to have severe, reversible neutropenia, apparently due to marrow suppression; platelets and RBCs were also reversibly suppressed in one." | 3.66 | Severe, reversible neutropenia during high-dose mebendazole therapy for echinococcosis. ( Axelrod, JL; Levin, MH; Schantz, PM; Weinstein, RA, 1983) |
| "The occurrence of transient leukopenia with relative neutropenia in a patient treated with a short course of high-dose mebendazole therapy for inoperable hydatid disease is reported." | 3.66 | Leukopenia associated with mebendazole therapy of hydatid disease. ( Javitt, NB; Miskovitz, PF, 1980) |
| "Fifteen patients with inoperable hydatid disease (Echinococcus granulosus) were treated with an initial 6-week high-dose mebendazole regimen with a follow-up ranging from 3-7 years." | 1.27 | Long term follow-up of human hydatid disease (Echinococcus granulosus) treated with a high-dose mebendazole regimen. ( Kammerer, WS; Schantz, PM, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kammerer, WS | 1 |
| Schantz, PM | 2 |
| Davidson, RA | 1 |
| Levin, MH | 1 |
| Weinstein, RA | 1 |
| Axelrod, JL | 1 |
| Miskovitz, PF | 1 |
| Javitt, NB | 1 |
| Fernández-Bañares, F | 1 |
| González-Huix, F | 1 |
| Xiol, X | 1 |
| Catalá, I | 1 |
| Miró, J | 1 |
| López, N | 1 |
| Casais, L | 1 |
5 other studies available for mebendazole and Neutropenia
| Article | Year |
|---|---|
Long term follow-up of human hydatid disease (Echinococcus granulosus) treated with a high-dose mebendazole regimen.
Topics: Adolescent; Adult; Aged; Benzimidazoles; Child; Echinococcosis; Echinococcosis, Hepatic; Echinococco | 1984 |
Issues in clinical parasitology: the management of hydatid cyst.
Topics: Adult; Combined Modality Therapy; Echinococcosis, Hepatic; Female; Humans; Male; Mebendazole; Middle | 1984 |
Severe, reversible neutropenia during high-dose mebendazole therapy for echinococcosis.
Topics: Aged; Agranulocytosis; Benzimidazoles; Bone Marrow; Echinococcosis, Hepatic; Echinococcosis, Pulmona | 1983 |
Leukopenia associated with mebendazole therapy of hydatid disease.
Topics: Aged; Benzimidazoles; Echinococcosis; Female; Humans; Leukopenia; Mebendazole; Neutropenia; Tomograp | 1980 |
Marrow aplasia during high dose mebendazole treatment.
Topics: Aged; Agranulocytosis; Bone Marrow; Echinococcosis, Hepatic; Humans; Leukocyte Count; Male; Mebendaz | 1986 |